T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
43 hedge funds and large institutions have $12.8M invested in T2 Biosystems, Inc in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 12 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
10% less funds holding
Funds holding: 48 → 43 (-5)
31% less call options, than puts
Call options by funds: $70K | Put options by funds: $102K
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
54% less capital invested
Capital invested by funds: $27.6M → $12.8M (-$14.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$435K |
| 2 |
Morgan Stanley
New York
|
+$236K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$189K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$123K |
| 5 |
LCS
Levin Capital Strategies
New York
|
+$113K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$830K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$506K |
| 3 |
KeyBank National Association
Cleveland,
Ohio
|
-$163K |
| 4 |
Barclays
London,
United Kingdom
|
-$162K |
| 5 |
Millennium Management
New York
|
-$104K |
TTOO Hedge Fund Activity: Q4 2019 in Review
43 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2019, worth a combined $12.8M — down 54% from $27.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TTOO and 7 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $435K. The largest seller was Essex Investment Management, exiting entirely with an estimated $830K sold.
- 43 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2019, down from 48 in Q3 2019.
- Funds reported $12.8M of T2 Biosystems, Inc stock for Q4 2019, down 54% quarter-over-quarter.
- 7 funds opened new T2 Biosystems, Inc positions in Q4 2019 and 12 closed out, a net change of -5 holders.
- The largest T2 Biosystems, Inc buyer in Q4 2019 was D.E. Shaw & Co, an estimated $435K added.
- The largest T2 Biosystems, Inc seller in Q4 2019 was Essex Investment Management, an estimated $830K sold.
Based on aggregated 13F filings for Q4 2019.